Understanding and explaining viral vector COVID-19 vaccines

i

Understanding and explaining viral vector COVID-19 vaccines

Supporting Files Public Domain

February 17, 2021
By National Center for Immunization and Respiratory Diseases (U.S.)

File Language:

English

Details

Corporate Authors:

National Center for Immunization and Respiratory Diseases (U.S.)
Description:

Several COVID-19 vaccine candidates entering late-stage clinical trials are what is known as viral vector vaccines. These vaccines are likely to be among the COVID-19 vaccines authorized for use in the United States. This page provides background and safety information about these vaccines for healthcare professionals and other vaccine providers, as well as tips for explaining viral vector vaccines to patients.
Subjects:

Coronavirus Infections/prevention & Control COVID-19 Vaccines Genetic Vectors Viral Vaccines
Document Type:

Webpage
Collection(s):

Stephen B. Thacker CDC Library
Main Document Checksum:

urn:sha256:afa6529dec948d80c0d14650060e27ecf842c108ec46c66b94e6bc2bfbf57ff0
Download URL:

https://stacks.cdc.gov/view/cdc/103607/cdc_103607_DS1.pdf
File Type:

[PDF - 95.75 KB ]

viral-vector-vaccine-basics.html

html

File Language:

English

ON THIS PAGE

Details Supporting Files

CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.

As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.